Douglas Janzen

Douglas Janzen

Director Ejecutivo en AEQUUS PHARMACEUTICALS INC. .

Fortuna: 12 554 $ al 31/07/2026

58 años
Health Technology
Finance
Commercial Services

Perfil

Douglas Glen Janzen is the founder of Aequus Pharmaceuticals, Inc., founded in 2013, serving as Chairman, President & Chief Executive Officer.
Mr. Janzen is the founder of Northview LifeSciences, founded in 2014.
Mr. Janzen is the founder of Northview Ventures & Associates General Partnership, founded in 2014, serving as Managing Director.
Current jobs include Chairman at Lexington Biosciences Holdings Corp.
since 2017, Director & Managing Director at LifeSciences British Columbia since 2010, Director at Synaptive Technologies Ltd., Director at Transdermal Research Pharm Laboratories LLC since 2013, and Director at Alabaster Technologies, Inc. Former jobs include President, Chief Executive Officer & Director at Correvio Pharma Corp.
from 2010 to 2012, Chairman at AbCellera Biologics, Inc., Chairman at Lexington Biosciences, Inc. from 2016 to 2021, Chairman at Perimeter Medical Imaging, Inc., Director at Medical Ventures Corp., Director at Teal Valley Health, Inc., Director at Aptamera, Inc., Director at Synaptive Medical, Inc., Director at BIOTECanada, Independent Director at iCo Therapeutics, Inc. from 2012 to 2015, Director at Sentinelle Medical ULC, Independent Director at Neovasc, Inc., Director at BioHEP Technologies Ltd., Director at Renaissance BioScience Corp., Director at AmpHP, Inc., Director at Perimeter Medical Imaging AI, Inc., Analyst at Cormark Securities, Inc. in 2002, President & Chief Business Officer at Bradmer Pharmaceuticals, Inc. from 2006 to 2007, and Head of Research at Loewen, Ondaatje, McCutcheon Ltd. in 2001.
Education includes graduate degree from the University of British Columbia and undergraduate degree from the University of Saskatchewan.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/09/2025 12.553.800 ( 9,46 % ) 12 554 $ 31/07/2026

Cargos activos de Douglas Janzen

EmpresasCargoInicio
AEQUUS PHARMACEUTICALS INC. Director Ejecutivo 03/01/2013
Fundador 01/04/2014
Alabaster Technologies, Inc.
Director/Miembro de la Junta -
Presidente 23/05/2017
Director/Miembro de la Junta 03/03/2013
Synaptive Technologies Ltd.
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Fundador 01/04/2014

Antiguos cargos conocidos de Douglas Janzen.

EmpresasCargoFin
REGISTERED PLAN PRIVATE INVESTMENTS INC. Presidente 01/12/2021
░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Douglas Janzen.

Formación de Douglas Janzen.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

53

Relaciones de 1er grado

29

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas29

Finance

Health Technology

Electronic Technology

Technology Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Commercial Services

Synaptive Technologies Ltd.

Commercial Services

Health Technology

Alabaster Technologies, Inc.

Health Technology

Health Technology

Health Technology

Finance